Trevigen's Acquisition

Trevigen was acquired by Bio-Techne on September 05, 2017.

Trevigen is focused on the development of products and technologies for cancer research, drug discovery, genetic toxicology, regenerative medicine, and stem cell work. It offers kits and reagents for …

Articles about Trevigen's Acquisition: